During the course of an open ‘paella’ that brought together eight hundred people in the Cúbic space of Viladecans, the Association Viladecans Against Cancer officially offered a 20,000 euros check to IDIBELL for the investigation of a new treatment for cancer metastasis of unknown origin, led by Dr. Manel Esteller (Epigenetics and Cancer Biology program […]
The detailed description of the biology of the PIK3CA gene has allowed to understand how venous malformations and other overgrowth disorders, such as cancer, develop.
Pioneered by Virgil H. Simons, Founder and President of the patient education and advocacy group The Prostate Net, an annual series of workshops and symposia aimed at increasing public awareness on and around the importance of cancer science and clinical discovery in advancing precision medicine cancer care for patients suffering from prostate cancer has just launched. Co-organized
The association has made two donations of € 9,000 to the research groups of Dr. Miguel Gil and Dr. Jordi Guardiola, IDIBELL researchers and doctors from the Catalan Institute of Oncology and the Bellvitge University Hospital.
Occupational risk management at the Bellvitge Biomedical Research Institute (IDIBELL) has been awarded with an honorable mention by MC MUTUAL, a social security-linked mutual insurance company, within the XVII Edition of the MC MUTUAL “Antonio Baró” Awards for Occupational Risk Prevention, given to the companies, people and institutions that excel when it comes to effectively
Occupational risk management at IDIBELL is recognized by MC MUTUAL “Antonio Baró” Awards Read More »
A collaborative research project between IDIBELL-ICO, Jordi Gol IDIAP and IGTP identifies the main diseases that contribute to it
Understanding multimorbidity to improve prevention Read More »
Autoimmune rheumatic diseases like rheumatoid arthritis, lupus and scleroderma are debilitating and occasionally life-threatening. An EU and industry-funded project aims to improve treatment by getting the right therapies to the right patients, fast.
Looking for a fast, effective treatment for autoimmune rheumatic diseases Read More »
The theme for the 2018 International Open Access Week, to be held October 22-28, will be “designing equitable foundations for open knowledge.” This year’s theme reflects a scholarly system in transition. While governments, funders, universities, publishers, and scholars are increasingly adopting open policies and practices, how these are actually implemented is still in flux.
Open Access Week at IDIBELL Read More »
IDIBELL takes part in the HEALTHIO and BioJapan trade fairs
IDIBELL’s health innovation model visits Barcelona and Japan Read More »
Bellvitge Biomedical Research Institute (IDIBELL) and the Catalan Institute of Oncology (ICO) will join the pink movement associated with the celebration of Breast Cancer World Day. Thus, the facade of the Duran i Reynals Hospital (Granvia de l’Hospitalet 199-203) will turn pink, the night of Friday, October 19th, World Day Against Breast Cancer, to remember the importance of early
IDIBELL and ICO turn pink for Breast Cancer World Day Read More »
